Ion Beam Therapy Center, SAGA HIMAT Foundation, Tosu, Japan, 415 Harakoga-machi, Tosu, 841-0071, Japan.
Anticancer Res. 2013 Dec;33(12):5579-84.
The purpose of this study was to evaluate the role of FDG-PET regarding the indication of preoperative carbon-ion radiotherapy (CIRT) for pancreatic cancer patients.
Patients with resectable pancreatic cancer underwent preoperative CIRT. The impact of baseline SUVmax on prognosis for patients was assessed by analyzing correlations with distant metastasis-free survival (DMFS) and overall survival (OS).
Out of 21 patients, local recurrence was observed in no patient and distant metastasis was found in 13 patients (62%). 1-year DMFS and OS in low-SUVmax group were significantly higher than those in high-SUVmax group (91% vs. 20% and 91% vs. 56%). SUVmax was significantly correlated with DMFS and OS.
Our data indicated a significant correlation between SUVmax and DMFS. FDG-PET might be useful for determining the indication of preoperative short-course CIRT for patients with resectable pancreatic cancer.
本研究旨在评估氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)在胰腺癌患者术前碳离子放疗(CIRT)适应证中的作用。
可切除胰腺癌患者接受术前 CIRT。通过分析与无远处转移生存(DMFS)和总生存(OS)的相关性,评估基线 SUVmax 对患者预后的影响。
21 例患者中,无局部复发,13 例(62%)发生远处转移。低 SUVmax 组的 1 年 DMFS 和 OS 明显高于高 SUVmax 组(91%比 20%和 91%比 56%)。SUVmax 与 DMFS 和 OS 显著相关。
我们的数据表明 SUVmax 与 DMFS 之间存在显著相关性。FDG-PET 可能有助于确定可切除胰腺癌患者术前短程 CIRT 的适应证。